Skip to main content
. 2023 May 16;33(11):7631–7645. doi: 10.1007/s00330-023-09725-7

Fig. 3.

Fig. 3

Kaplan-Meier curves demonstrating differences in OS between the OSASH-low and OSASH-high risk patients with HCC in the (A) training, (B) internal validation, and (C) external validation cohorts. HCC, hepatocellular carcinoma; OS, overall survival